A randomised trial comparing 8 cycles of CPT11 with CPT11 until disease progression in patients with colorectal cancer resistant to 5-fluorouracil

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2002
INTERVENTION: 1. CPT11 350 mg/m2 IV over 30 min every 3 weeks 2. No treatment CONDITION: Colorectal cancer ; Cancer ; Colorectal PRIMARY OUTCOME: Not provided at time of registration SECONDARY OUTCOME: Not provided at time of registration INCLUSION CRITERIA: 1. Histological evidence of metastatic adenocarcinoma of colon or rectum not amenable to surgery or radiotherapy 2. Documented evidence of disease progression by Computed Tomography (CT) within 24 weeks of last 5FU
Epistemonikos ID: feebe4ca75038e9d77cfbaaf4332eded0ac7c87f
First added on: Aug 21, 2024